• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Q Bio Launches Clinical “Digital Twin” Platform, Whole Body Scanner

by Jasmine Pennic 04/30/2021 Leave a Comment

What You Should Know:

– Q Bio, a Redwood City, CA-based company building technology for the Physical of the Future, unveiled its “digital twin” platform, the first to capture and monitor comprehensive baseline patient health in a scalable virtual model.

– In addition, the company announced an investment from Kaiser Foundation Hospitals that brings its total capital to more than $80 million, including Series B funding led by Andreessen Horowitz, to develop and expand access to its proprietary platform and breakthrough whole-body scanning technologies that enable data-driven, proactive, and more affordable preventive care for all. 

 Q Bio Gemini Platform

The company’s platform, called Q Bio Gemini, automatically reflects an individual’s most accurate physiological state in the form of a digital twin, highlighting the most important changes in a person’s physiology in a comprehensive summary that can be securely shared with physicians and specialists all over the world. 

Powering the Gemini platform is the Q Bio Mark I self-driving, whole-body scanner – the fastest, most accessible scanner developed, and the first scanner optimized for proactive care. The Mark I scanner collects information based on current health and personal risks, adapting in real time to changes in an individual’s anatomy and biochemistry that are weighted by lifestyle, medical history, and genetic risk factors. Capable of scanning the whole body in 15 minutes or less without radiation, breath holds, or claustrophobia, the scanner provides individuals with maximum comfort in an open space, including the option to stand, sit, or lie down. 

The Mark I offers faster and more precise medical scanning without the use of artificial intelligence or machine learning, avoiding issues with bias and “hallucinations.” The company’s technology, which is based on advanced computational biophysics, has been shown to be at least 10x faster than conventional MRI scans without the loss of diagnostic quality, and allows  for the construction of dramatically cheaper hardware, with rapid deployment and reduced operational costs. 

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |